Crossmark

Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance”

Crossref DOI link: https://doi.org/10.1007/s40744-024-00740-8

Published Online: 2025-01-20

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Goyal, Manjeet Kumar https://orcid.org/0000-0002-5511-2099
License Information

Text and Data Mining valid from 2025-01-20

Version of Record valid from 2025-01-20
More Information

Article History

Received: 1 August 2024

Accepted: 16 December 2024

First Online: 20 January 2025

Declarations

:

: Manjeet K. Goyal has nothing to disclose.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by the author.

Document is current

Any future updates will be listed below